%PDF-1.6
%
3 0 obj
<>
endobj
30 0 obj
[/CalGray<>]
endobj
31 0 obj
[/CalRGB<>]
endobj
32 0 obj
<>stream
application/pdf
Commission de la transparence
Zyprexa, Olanzapine, Avis de transparence
Avis de transparence Zyprexa, Olanzapine, inscription, decembre 2001
Zyprexa
Olanzapine
Comprimés orodispersibles
5mg
10mg
15mg
20 mg
schizophrénie
avis
transparence
inscription
Lilly
ASMR
SMR
population cible
2001
2002-02-15T15:10Z
Microsoft Word
2013-07-25T14:38+02:00
2013-07-25T14:38+02:00
Acrobat PDFWriter 5.0 pour Windows
Zyprexa, Olanzapine, Comprimés orodispersibles; 5mg; 10mg; 15mg; 20 mg, schizophrénie, avis, transparence, inscription, Lilly, ASMR, SMR, population cible, 2001
uuid:addb4f42-aa81-4a2d-b7b0-2a1557b24fff
uuid:32a72219-6ee2-457f-ba6a-120d660befce
endstream
endobj
5 0 obj
<>
endobj
4 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
12 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
17 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
20 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
23 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
24 0 obj
<>stream
HVn#7C 6n x#Iݢ%V}[ki4ADWP
`k}@!,k 3\;Xq氠>//HBh'4)K7 sʩ݈mg3(Y=z?{uZ_)3HmK~`YE/qzyaT Yn֞h[ b;2duB2g*=30zܑ3ۨ^;HUJբ,jJ3VAs삺